Menstruation stabilization

"Menstruation stabilization" refers to the clinical concept of reducing or normalizing menstrual bleeding or the prevention of abnormal menstrual cycles, often targeted in therapies for menorrhagia or other menstrual disorders. There is no single molecular target or receptor identified as "menstruation stabilization"; instead, the process involves complex hormonal and cellular regulation of the endometrium by interactions among the hypothalamus, pituitary, ovaries, and uterus. Key molecular targets in menstrual regulation include nuclear hormone receptors (estrogen receptor, progesterone receptor), enzymes (aromatase, cyclooxygenase), cytokines, and chemokines involved in endometrial function and cycle progression[1][4][6]. Drugs that "stabilize menstruation" act via various targets affecting ovulation, endometrial stability, or hemostasis, but there is no "menstruation stabilization" receptor or molecule per se[6].